Advances in 3D bioprinting for cancer biology and precision medicine: From matrix design to application
MS Jung, S Ghamrawi, EY Du… - Advanced …, 2022 - Wiley Online Library
The tumor microenvironment is highly complex owing to its heterogeneous composition and
dynamic nature. This makes tumors difficult to replicate using traditional 2D cell culture …
dynamic nature. This makes tumors difficult to replicate using traditional 2D cell culture …
Bioprinting the cancer microenvironment
Cancer is intrinsically complex, comprising both heterogeneous cellular compositions and
microenvironmental cues. During the various stages of cancer initiation, development, and …
microenvironmental cues. During the various stages of cancer initiation, development, and …
Advances in 3D bioprinting for the biofabrication of tumor models
MG Sánchez-Salazar, MM Álvarez… - Bioprinting, 2021 - Elsevier
Cancer research depends on the challenging task of producing representative and reliable
models of human disease; these have largely been limited to mouse models or human …
models of human disease; these have largely been limited to mouse models or human …
3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing
D Nothdurfter, C Ploner, DC Coraça-Huber… - …, 2022 - iopscience.iop.org
Neuroblastoma is an extracranial solid tumor which develops in early childhood and still has
a poor prognosis. One strategy to increase cure rates is the identification of patient-specific …
a poor prognosis. One strategy to increase cure rates is the identification of patient-specific …
[HTML][HTML] Immersion bioprinting of tumor organoids in multi-well plates for increasing chemotherapy screening throughput
E Maloney, C Clark, H Sivakumar, KM Yoo, J Aleman… - Micromachines, 2020 - mdpi.com
The current drug development pipeline takes approximately fifteen years and $2.6 billion to
get a new drug to market. Typically, drugs are tested on two-dimensional (2D) cell cultures …
get a new drug to market. Typically, drugs are tested on two-dimensional (2D) cell cultures …
Three-dimensional bioprinting of in vitro tumor organoid and organ-on-a-chip models
In the past decade, organoid and organ-on-a-chip cancer models have rapidly gained
attention as alternatives to traditional two-dimensional cell cultures and murine models …
attention as alternatives to traditional two-dimensional cell cultures and murine models …
[HTML][HTML] Recapitulating the cancer microenvironment using Bioprinting technology for precision medicine
The complex and heterogenous nature of cancer contributes to the development of cancer
cell drug resistance. The construction of the cancer microenvironment, including the cell–cell …
cell drug resistance. The construction of the cancer microenvironment, including the cell–cell …
3D bioprinting tumor models mimic the tumor microenvironment for drug screening
X Mi, Z Su, X Yue, Y Ren, X Yang, L Qiang… - Biomaterials …, 2023 - pubs.rsc.org
Cancer is a severe threat to human life and health and represents the main cause of death
globally. Drug therapy is one of the primary means of treating cancer; however, most …
globally. Drug therapy is one of the primary means of treating cancer; however, most …
3D bioprinting of tumor models for cancer research
The exact mechanistic understanding of cancer metastasis continues to be unknown,
although it is a major cause of death worldwide. Along with the tumor mass, the tumor …
although it is a major cause of death worldwide. Along with the tumor mass, the tumor …
[HTML][HTML] The tumor-on-chip: Recent advances in the development of microfluidic systems to recapitulate the physiology of solid tumors
G Trujillo-de Santiago, BG Flores-Garza… - Materials, 2019 - mdpi.com
The ideal in vitro recreation of the micro-tumor niche—although much needed for a better
understanding of cancer etiology and development of better anticancer therapies—is highly …
understanding of cancer etiology and development of better anticancer therapies—is highly …